Ministry of Food Agriculture and Livestock, General Directorate of Control and Protection, Adana Provincial Food Control Laboratory, TURKEY
Senior Technical Officer, Quality Control & Quality Assurance, Indian Institute of Integrative Medicine, India
Director of Laboratory, Center for Mental Disease Control and Prevention, Third Hospital of the Peopleââ¬â¢s Liberation Army
Institute of Control Agents for Microorganisms, Korea University, Korea, Email: yjchang10@korea.ac.kr
Department of Food Control, Faculty of Veterinary Medicine, Moshtohor, Benha University, Egypt.
Professor of Harran University, Bozova Vocational School, Department of Environmental Protection Technologies, Environmental Protection and Control Program, 63850 Bozova/Sanl?urfa, Turkey
Associate Service Fellow, Health Effects Laboratory Division National Institute for Occupational Safety and Health (NIOSH) Department of Health and Human Services (DHHS), Centers for Disease Control (CDC) and Prevention U.S.
Department of Food safety & Quality Control, Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences, Address: No 1, Nongda South Road, Xibeiwang Town, Haidian District, Beijing, 100193 P.R. China
Hospital Pharmacist Manager, Director Hospital Medicinal Gas Quality Control Ausl Pc, Italy
State key Joint Laboratory of Environment Simulation and Pollution Control, School of Environment, Tsinghua University, Beijing 100084, P.R. China
Deputy Director at Pathology Department, Sir Run Run Shaw Hospital, Zhejiang University Medical School, Hangzhou, China. Member of Pathology Committee, Zhejiang Medical Association Member of Pathologists Committee, Chinese Laboratory Medicine Committee Member of Cancer Target Therapy Committee, Chinese Anti-Cancer Association Member of Molecular Pathology Group, Pathology Quality Control Center of China Member of Molecular Pathology Committee, Chinese Pathologist Association Member of Molecular Pathology Committee, Chinese Society of Pathology
Author(s):
Renato Rafael Costa Lima, Olga Maria Telo Pousa, Mikaelle Oliveira Campos, Sandra Irene Duarte Monteiro Pereira, Saulo Dutra Ávila Pinheiro
Author(s): Aklilu Endalamaw Sinshaw, Demeke Geremew, Habte Belete, Sintayehu Ambachew, Berihun Assefa, Tesfa Dejenie Habtewold,
Rhonda Wilson
Author(s): Ebede S1, Nwafia I1* , Ohanu M1, Ozumba U1, Chukwuka C2 and Onyedum C2
Author(s): US Food and Drug Administration (FDA) exercises flexibility in the requirement that new drugs provide substantial evidence of benefit under the Food, Drug and Cosmetic Act. Provisions in law and policy provide numerous exceptions to the historical scientific standard of 2 or more controlled clinical trials demonstrating statistically significant evidence of benefit.